04/24/2017 - 11:02pm

Actions being taken are part of Sears’ continuing corporate restructuring program.

04/24/2017 - 6:01pm

The Dr. Reddy’s progesterone capsules — recently approved by the Food and Drug Administration — will be available in 100- and 200-mg dosage strengths. 

04/24/2017 - 5:54pm

The transaction is expected to close by early 2018 and to be accretive in 2018 to Fresenius Group net income and EPS, excluding integration costs.

04/24/2017 - 5:47pm

PharmaSmart said it will deploy its clinically validated blood pressure kiosk and cloud-based Health IT platform across Coborn’s 36 grocery stores with pharmacies, which operate under the banners of: Coborn’s, Cash Wise Foods, and Market Place Foods across Minnesota, South Dakota, and Wisconsin.

04/24/2017 - 5:24pm

Colleen Lindholz has been president of The Little Clinic since 2015 and takes over pharmacy duties from Philecia Avery, who Kroger said resigned the company earlier this month to pursue other interests.

04/21/2017 - 7:28pm

Renflexis, marketed by Merck and developed by South Korea's Samsung Bioepis, is the second FDA-approved biosimilar to Johnson & Johnson’s Remicade.

04/21/2017 - 6:33am

Perphenazine Tablets USP, 2 mg, 4 mg, 8 mg and 16 mg are the generic version of the reference listed drug, Trilafon Tablets 2 mg, 4 mg, 8 mg and 16 mg, originally marketed by Schering. 

04/20/2017 - 3:04pm

Drugs are used for the treatment of asthma in patients aged 12 years and older who are uncontrolled on an inhaled corticosteroid or whose disease severity clearly warrants the use of an ICS/long-acting beta2-adrenergic agonist combination.

04/20/2017 - 2:22pm

The drug is a once-daily oral maintenance treatment indicated to treat women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.